Sinjard-M
Indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus when treatment with both Empagliflozin & Metformin Hydrochloride is appropriate. And Empagliflozin reduces the risk of heart failure and chronic kidney disease.
Features
| Product Name | Sinjard-M |
| Generic Name | Empagliflozin + Metformin Hydrochloride |
| Therapeutic Class | SGLT-2 inhibitor + Biguanides |
| Formulation | Tablet |
| Available Pack Size | 4 X 7’s |
| Available Strength | Available Strength Empagliflozin 5 mg + Metformin Hydrochloride 500 mg |